a 2023

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL.

PAVLOVÁ, Šárka, Jitka MALČÍKOVÁ, Lenka RADOVÁ, Michael DOUBEK, Tereza BOROŠOVÁ et. al.

Basic information

Original name

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL.

Edition

The 65th ASH Annual Meeting and Exposition, San Diego, California, USA in Blood, 2023

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Central European Institute of Technology
Changed: 8/1/2024 09:05, Bc. Kateřina Kolesová